Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation

Clinical trial NCT06187311 · RECRUITING

Trial details

NCT number: NCT06187311
Sponsor: Korea University Anam Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Anticoagulant Adverse Reaction

Start date: 2023-01-12
Primary completion: 2026-06-30
Enrollment: 940

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.